Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
Acute myocardial infarction (AMI) resulting in cardiogenic shock continues to be a substantial source of morbidity and mortality despite advances in recognition and treatment. Prior to the advent of percutaneous and more durable left ventricular support devices, prompt revascularization with the add...
Saved in:
| Main Authors: | Pratik K. Dalal, Amy Mertens, Dinesh Shah, Ivan Hanson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2019/4591250 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recognizing Post-Cardiac Injury Syndrome After Impella 5.5 Insertion in Cardiogenic Shock: A Case-Based Discussion
by: Aarti Desai, et al.
Published: (2025-07-01) -
A Review of the Impella Devices
by: Rami Zein, et al.
Published: (2022-04-01) -
Impella‐Protected High‐Risk Percutaneous Coronary Intervention in the Elderly: Balancing Feasibility and Necessity
by: Margriet Bogerd, et al.
Published: (2025-05-01) -
Impella 5.5 use in women: A multicenter study
by: Michaela Asher, MPhil, et al.
Published: (2025-08-01) -
Short- and long-term outcomes of Impella-protected, high-risk, elective PCI in patients with multivessel coronary disease and low ejection fraction — Polish Impella Registry
by: Wojciech J. Skorupski, et al.
Published: (2025-06-01)